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Abstract:  Adherence to treatment is recognized as the essence of a successful HIV combination therapy. Optimal 
adherence implies a readiness to begin the treatment on the part of the patient. A better understanding of the "readiness 
phenomenon" will become an asset for optimizing HIV treatment. However, few studies have focused on understanding 
the process underlying the choice to adhere. The aim of this study is to understand the readiness process that leads to 
adhering to the HIV treatment, from both patient and professional perspectives. Twenty-seven in-depth interviews, with a 
qualitative exploratory design, were the source of our data. Participants were recruited in two hospitals in Paris. 
Throughout the data-collection process, analysed data were supplied to all participants and the research team, thus 
allowing for shared constructions. Four themes, interrelated with a constitutive pattern, emerged from the data we 
collected. Being ready to begin and adhere to treatment is a matter of confidence in oneself, as well as in relatives, in the 
treatment and in the health professional team. These themes are not constant and unvarying; instead, they constitute a 
picture moving across time and life events. Results of this study show that adherence that goes beyond “complying with” 
the medical instructions, but depends on how much of an active role the patient plays in the choice to adhere. 
Keywords: Readiness  HIV treatment adherence qualitative study. 
INTRODUCTION 
  Although the adoption of Highly Active Anti-Retroviral 
Therapy (HAART) as the standard of care for people living 
with HIV/AIDS has contributed significantly to reducing 
HIV-related morbidity and mortality [1-3], living with HIV 
remains a constant challenge. As well as facing the problems 
related to chronic disease, the patient must manage a 
complex and changing treatment regimen and adhere to it. It 
has been well documented that near-perfect HIV medication 
adherence (i.e., at least 95% of the medication) is required 
for optimal viral suppression [4-6]. There is a strong linear 
relationship between adherence and a reduction in HIV viral 
load and limited adherence has been linked with acquisition 
of HIV-drug-resistant mutations [4, 7]. Despite this 
incentive, substantial numbers of HIV-positive individuals 
are currently failing treatment because of non-adherence. 
  Several factors have been found to influence patient 
adherence [8]: age [9, 10], duration of treatment [7, 11], drug 
or alcohol problems [12], psychiatric disorders [6], 
interaction between patients and care providers [13], social 
support [14], confidence in antiretroviral treatment [15] and 
“readiness” for treatment [16-19]. Readiness is defined as, 
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“A conscious awareness, on the part of an individual, based 
on free will, that he has considered and determined that a 
particular behaviour change (i.e., taking his anti-HIV 
medication as prescribed) will be beneficial.” [20, p.2]. We 
now recognize that the treatment should be arranged and 
available but commencement delayed until, as the individual 
is ‘ready’ to adhere to it [21, 22]. Optimal adherence thus 
entails a ‘readiness’ on the part of the patient to start and 
stick to the treatment [23]. Health professionals are therefore 
challenged to develop evaluation and intervention 
approaches that focus on adherence to treatment. A better 
understanding of the “readiness phenomenon” should be an 
asset in optimizing the quality of interventions. 
  Although one particular study by Enriquez and 
colleagues demonstrates that readiness is a key factor in 
successful adherence to antiretroviral treatment [17], 
readiness  is a phenomenon that has not been a major 
discussion point in the field of HIV/AIDS [24, 25]. Few 
studies have examined the relation between readiness and 
adherence to HIV treatment, nor tried to understand the 
process that leads to becoming adherent [19]. As far as we 
know, no studies based on both patients’ and professionals’ 
perspectives have been conducted in a French-speaking 
country. The aim of this qualitative study is to examine and  
describe the readiness process for taking up complete 
adherence to HIV treatment, from both patient and 
professional points of view. 
MATERIALS AND METHODS 
  We chose a qualitative exploratory design to examine the 
readiness process as a human experience and to perform it 
from a hermeneutic constructivist perspective [26, 27]. 
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Infectious Diseases Departments of two hospitals in Paris, 
France. To understand variation in the readiness process 
better, we classified prospective participants in three groups. 
We started with beginners (beginning treatment in the next 
three months) and adherents (viral load under 50 copies and 
self-administered questionnaire) and we added non-adherent 
patients (viral load over 50 copies and showing non-
observance recognized by medical team) subsequently 
during the research process. Clinical research nurses working 
in these departments asked patients they interacted with to 
participate. They were screened using two criteria to 
determine eligibility: viral load under 50 copies and 
compliance rate over 95%, as determined by a self-
administered questionnaire [28]. Professionals who had 
having at least two years clinical experience, were also 
recruited from these two departments. 
Procedures 
  The research team was composed of professionals from 
the two hospitals. The team was composed of the two 
principal investigators, two research collaborators and seven 
clinic collaborators (six nurses and a physician). We used 
qualitative research techniques for preparing the interview 
guide, for developing interviewers skills and the for analysis 
process. We continued using these techniques to perform 
individual and collective coding for the first five interviews. 
This generated a second form of validation to increase rigor 
in the analytic process. 
  Interviews were carried out over an eight-month period 
by four members of the research team. To avoid potential 
biases, we made certain that interviewers had not previously 
known the participants in a clinical context. An ethics 
certificate (CER-38-95) was issued by the Research Ethics 
Committee of the first author’s university. Following an 
explanation of the study, its purpose and the participants’ 
rights with regard to the project. We obtained written 
consent from those willing to participate. 
  Data were collected in semi-structured interviews with 
individuals. Each interview began with a written 
questionnaire for socio-demographic data, and for 
information about prescribed HIV medication. To ensure 
unity in all interviews, we developed two interview guides 
(one for each group). These were validated by the research 
team. The interviews included questions about patients’ 
individual history, in terms of adherence to treatment and 
about professionals’ experience with adherence issues. As 
well, there were questions about the readiness phenomenon 
itself, as it is experienced (patients) or observed 
(professionals). With the exception of the first interview, 
validation questions were added by anonymously 
introducing other participants’ responses, in addition to 
introducing the themes emerging from the analysis in 
progress. This is recommended by Guba and Lincoln [26]. 
Interviews were recorded on audiotape and were transcribed 
by doctoral sociolinguistics students. At mid-analysis, we 
organized a meeting attended by the transcribers and the 
research team. This was very useful for reducing 
misinterpretations of the taped interviews among the 
interviewers and transcribers. 
 
  Analysis began with each interview transcript [29] being 
read by each member of the research team. A synthesis of 
each interview was then written after the transcript was read. 
This enabled us to identify emergent themes for thematic 
analysis, which involved establishing units of information 
(unitizing)  and  classifying them into categories 
(categorizing) [30]. To help manage, shape and make sense 
of unstructured information, we used NVivo© qualitative 
analysis software to support the analytic process. 
FINDINGS 
Participants 
  Twenty-seven individuals, patients and professionals, 
agreed to participate by means of interviews, which lasted an 
average of 45 minutes. Most participants were male (88%) and 
most professionals were female (66%). Mean age of patients 
was 43 years, ranging from 30 to 59 years. Patients had been 
receiving HIV treatment for an average of 12.2 years. 
Professionals included physicians, nurses and a psychologist. 
All of them work in Infectious Diseases departments. They had 
an average of 14 years of clinical experience with HIV patients 
within range of 5-25 years, (see Table 1). 
Table 1.  Characteristics of Study Participants (N=27) 
 
Groups  N  Mean Years (Range) 
Patients 18   
Adhering 10   
Male/female 8/2   
Age   49  (30-79) 
Time since diagnosis     13 (2-20) 
Duration of treatment     12 (2-19) 
Non-adhering 5   
Male/female 5/0   
Age     39 (30-59) 
Time since diagnosis    15 (12-20) 
Duration of treatment    13 (12-15) 
Beginning   3   
Male/female 3/0   
Age     42 (30-59) 
Time since diagnosis    2 (1-3) 
Professionals 9   
Medical doctor  3/0   
Nurse 0/5   
Psychologist 0/1   
Clinical experience with HIV    14 (5-25) 
 
Stakeholders’ Contribution 
  Prior to exploring the shared construction, which was 
drawn from a consensus of all partners in this study, a brief 
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Patient Group 
  Eighteen patients participated in this study.  After ten 
interviews with high-adherence patients, we found certain 
regularity in the data related to the process of becoming 
ready to join.  Using purposive sampling, we continued 
recruitment to understand whether this process was the same 
when it was actually under way. To do this, we met people 
who were preparing for the start of treatment (beginner’s 
group).  We also met with patients who were identified as 
being non-adhering so that we could focus on similarities 
and differences in the emerging themes and see whether, 
depending on where the person was in the course of in his 
treatment, this made a difference. 
  Major themes revealed with the first group of adhering 
participants (ad) included the fact that readiness varies over 
the course of treatment. In fact, at the start of treatment, 
members of the adhering group reported needing little 
reflection because, for them, “It was a question of life or 
death” (ad1). However, in the course of treatment, some 
participants reported that there were variations in their own 
readiness over time. “There are 24 pills a day to take. At first 
it’s alright but sometimes you get fed up… but you tell 
yourself that if you want to get better you have to take them, 
if not you’re going to go under. If you want results, you have 
to fight; you can’t just let yourself go.” (ad8) 
  Thus, readiness come to be seen as a long-term process 
that fluctuates over time and, depending on events, continues 
to be present beyond the beginning of treatment. For all 
adhering patients interviewed, their relationship with the 
healthcare professional was crucial for maintaining the 
determination to continue treatment: “I think that what also 
matters a lot is the confidence we have in the medical 
personnel.” (ad7) While the training received and the follow-
up are very important, how the professional relates to patient 
is just as important, particularly her or his skill in listening to 
the patient. Support from family and friends is another factor 
commonly discussed by this group. “I live with someone and 
he is also ill…so when it’s difficult we keep up each-other’s 
spirit.” (ad3) 
  All interviews with this group reflect their active 
participation. Most of these individuals are professionally 
and socially committed, often to the cause of AIDS. They 
have a will to take active charge of their health: “When all is 
said and done, you have to take hold of yourself, you have to 
have enough character and personality to fight back.” (ad2) 
Moreover, seeing positive results encourages them to 
continue treatment: “As long as results are good, and for the 
moment they are… if I stop, I risk getting worse, so it’s not 
in my interest to stop. (ad1) This group of participants led us 
to realize that readiness is not necessarily a forerunner to 
adherence over time, but that it can constitute an essential 
factor for beginning, continuing or going back to treatment 
adherence. 
  As mentioned above, for balance in the project we met 
with three people who had not yet started treatment. For 
those participants, the only important thing at that point was 
to start receiving treatment. In fact, for the participants who 
were just beginning treatment (beg) whom we interviewed, 
making the decision to start did not require lengthy 
reflection: “There is no point in wasting time thinking… it 
has to be done… it has to, that’s all there is to it… there is no 
room for reflection.” (beg1) 
  All the beginning, participants said they felt lucky to be 
receiving treatment and they placed great hope in their 
treatment. Sometimes this hope was excessive: “What I want 
is to be totally cured by this medication.” (beg3) The major 
factor helping them start was the confidence they have in the 
treatment itself, as well as in the doctor and the medical 
team: “When someone gives me advice, if it comes from a 
person like a doctor or a teacher, I take the advice.” (beg2) 
Participants talked about means of preparing themselves, 
such as finding information by reading, searching the 
internet or by contacting support associations. Some 
participants rehearse the situation as a way of preparing for 
it: “I pretend I already have to take the medication.” (beg3) 
  For the beginning participants, being ready to start the 
treatment is a very personal feeling, experienced inwardly, 
and that does not require much thinking. However, all these 
participants agree on two major points: one must prepare by 
acquiring adequate information, and confidence in the doctor 
is essential. They know that this therapy is not easy. At this 
time, they know what the side-effects are, but have not 
experienced them. 
  Five participants whose medical records identified them 
as non-adhering (nonad) were added in the course of the 
project. We did this to get a better understanding of the 
readiness process over the longer term, as well as to examine 
similarities and differences in relation to the other groups. 
Individuals do not say that they ‘do not adhere to treatment’; 
usually they state something about ‘making a great effort and 
that it is difficult over a long term.’ All members spoke 
about the occurrence of side-effects: “Five times, no more, I 
had to stop for a bit, one or two days, three at the most, 
because I really had very bad headaches”  (nonad2). 
Constraints associated with taking the medication were often 
mentioned; however, it is not the constraint itself that is 
referred to, but the way in which it is experienced and the 
difficulty of assimilating it into everyday life. In addition, 
isolation and the wish to keep having the disease a secret 
were factors reported by all members of this group: 
“Anyway, since I get along on my own pretty well in 
general, I am a bit alone in my everyday life.” (nonad2) 
Confidence in the health professional is a theme discussed 
by all the members of this group. The interviews revealed 
that the heaviness of the treatment was a burden that 
participants were not always willing to carry, but that they 
continued to have great confidence in their physicians and 
their treatment. 
Professional Group 
  Interviews with caregivers in the professional group 
(prof) provided an additional perspective on the subject. 
Although they came from different disciplines, this nine-
person group worked with the same clientele and shared a 
common vision of adherence. In fact, they spoke of the 
importance of working in a multidisciplinary team and they 
recognized the advantages associated with this. “Group spirit 
is very, very important in ambulatory care.” (prof9) They all 
mentioned the important role of a relationship of confidence 
between the professional and the patient in promoting and 
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them to have confidence in their doctor, which is a 
fundamental rule of the doctor/patient relationship.” (prof8) 
  According to most members of the professional group we 
interviewed, having a profile as an active patient is very 
beneficial. The patient is presumably ready to adhere to the 
treatment when he takes an interest in it: “Once he becomes 
interested in his treatment, when it was explained to him, 
when he asked questions and has understood the treatment, 
how it works, what are the possible side-effects… I think 
this can be considered the thread that lets us suppose that he 
will adhere to the treatment.” (prof3) On this matter the 
professionals and the adhering group are in full agreement. 
  In addition, professionals consider ample preparation of 
the patient to be necessary for achieving good follow-up: 
“It’s a patient who has been prepared… rather than being 
given a treatment without psychological preparation…” 
(prof1) The individual’s support system is also a factor 
considered by most professionals to be influential in 
treatment adherence. Conversely, concealment and isolation 
are significant impediments. “ Like the other groups, the 
professionals viewed the adherence process as varying over 
time, and that being ‘ready’ not only applies before the start 
of treatment, but throughout its duration: “It would be very 
foolish to think that it’s acquired once and for all… everyone 
needs a little constant motivation to keep going.” (prof1) 
Shared Construction 
  We identified some regularities and common themes 
among the different groups in the data analysis. Analysis of 
the findings reveals a major pattern built around confidence. 
We found ‘confidence’ to be the only theme discussed by all 
participants, in every interview of the study. Confidence is 
the one characteristic that is essential to readiness. So, being 
ready to take charge of one’s health and treatment is a matter 
of confidence in oneself (as an actor), in relatives (social 
support), in the treatment (efficacy) and, most of all, in the 
health professional team. No themes are fixed forever; they 
constitute a moving picture across time and life events. 
DISCUSSION 
  The findings support other work that has explored the 
points of view of individuals living with HIV with regard to 
readiness. The only review of literature on readiness, as 
related to HIV treatment, shows that fear of side-effects, the 
shock of learning the diagnosis and lack of confidence in the 
physician and the medical team are the three major obstacles 
to overcome in achieving readiness [31]. The small number 
of beginning participants in our study did not make it 
possible for us to investigate the fear of side-effects. 
However, it is possible that confidence in the medical team, 
a theme that we were able to identify clearly, enabled 
patients to overcome this particular fear using information 
they believed to be reliable. The importance of knowledge, 
as well as of the support of friends and family, has been well 
documented in intervention studies [32]. This study is based 
on a way of taking charge of one’s health that corresponds 
rather closely to what participants report in this study. 
  In addition, it is interesting to note that the results of this 
study are in agreement with those presented by Enriquez and 
his colleagues about events that trigger readiness [33]. In this 
study, trigger events are described as change in either health 
status or in personal life status, such as disease progression 
due to non-adherence or the birth of a new family member 
[31]. The trigger, or change agent, causes individuals to re-
evaluate their lifestyles and produces a realization that 
behaviour changes are essential to continuing to live [33]. 
After the trigger event, a process with five components takes 
place: changing attitudes toward HIV medication, finding the 
right health providers, creating the right support system, 
getting control of life and having goals. Specifically, 
relationships with the health professional seem to be a 
critical factor [25], as it is in our study. At the start of 
HAART, patients report that the most important external 
resource is their physician (80%), followed by the family 
(39%) and then by the nurse, at 26.5%. Another study has 
shown similar results for the doctor/patient relationship at 
the start of therapy [34]. The same is true for the quality of 
the patient/nurse relation, which is recognized as being one 
of the main contributors to patient satisfaction, as well as 
being key to the choice of adopting positive long-term health 
behaviour [35]. This becomes very relevant in a context 
where a disease becomes chronic, as is the case with 
HIV/AIDS. The development of adherence consultation has 
been described by Valentini [36]. 
  Finally, a person’s commitment to his treatment seems to 
be an essential factor in readiness process. This factor was 
stressed by patients and professionals alike. A number of 
studies substantiate these results; one study in particular 
bears on the notion of taking control and examines the hardy 
personality in an adherence context [37]. Other research has 
focused on this phenomenon through the concept of 
empowerment, which goes beyond personality traits and 
takes into account the psycho-social context of the person 
living with HIV [38, 39], as does the Transtheoretical model 
(TTM) where readiness is a part of the process of deciding to 
maximize treatment adherence [40]. Three characteristics 
place adherence in an empowerment perspective: self-help 
behaviour, caregiver-patient cooperation and an active role 
in one’s own treatment [41]. In a chronic disease context, it 
therefore is important to consider the person as an actor in 
his or her own life and to reinforce his or her personal 
potential. This illustrates the contribution made by 
intervention studies using these theoretical foundations [31]. 
CONCLUSION 
  This research enabled us to integrate the perspectives of 
both professionals and patients in the same project. We used 
inter-group validation to arrive at a consensual construction 
that takes into account the different perspectives. This gives 
emphasis to the role of confidence as the central factor in the 
process of becoming ready to take charge of one’s health. 
Factors, such as the relationship with the health professional, 
social support and the self-confidence have also been shown 
to be important as triggers for readiness. It would be 
interesting to pursue this orientation in future research to 
develop and evaluate appropriate interventions. 
  It should be noted that participating patients were 
interviewed in a hospital environment, and therefore 
benefited, in a professional context, from the availability of 
additional support, making them less isolated than 
individuals might be in the community. This is a limitation 
of this qualitative study [42]. In a qualitative research Readiness in HIV Treatment  The Open AIDS Journal, 2011, Volume 5    123 
project, generalization of results is not required [43]; instead, 
the research focuses on the human experience by recognizing 
the possibility that it might also be shared with, for instance, 
other populations living with HIV or other chronic diseases 
associated with treatment adherence [44]. 
  Finally, it is important to mention that there is little 
experience in nursing research in France. This project may 
be seen as a contribution to the development of a team 
research culture in Nursing, as described elsewhere [45]. 
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